Form 144 RECURSION PHARMACEUTICALS For: 7 July

We’re selling 95 shares of CrowdStrike at roughly $205 each. Following Monday’s trade, Jim Cramer’s Charitable Trust will 785 shares of CRWD, decreasing its weight in the portfolio to 4% from 4.5%. We’re taking off some shares of CrowdStrike after another powerful run. CrowdStrike is up roughly 6% on Monday, trading at another record high….

Here’s a quick recap of the crypto landscape for Monday (July 6) as of 10:00 a.m. UTC. Get the latest insights on Bitcoin, Ether and altcoins, along with a round-up of key cryptocurrency market news. Bitcoin price update Bitcoin (BTC) was priced at US$62,716.60, down by 1.8 percent over the past 24 hours. Bitcoin price…

Pepperstone confirmed on Friday the appointment of Reed Sayer as its new Head of UK. Sayer joins from XTB, where he spent more than ten years building his career, most recently holding the position of Head of UK Sales. Over the course of his decade-plus tenure in financial services, he is said to have developed…

25 June 2026 Portfolios of non-financial corporate credit claims to be integrated into general collateral framework Implementation planned for November 2027 at the earliest Changes are final step in discontinuing temporary crisis-era collateral easing measures The Governing Council of the European Central Bank (ECB) has decided today on the eligibility criteria and risk control framework…

Floored: Basel III rethink upsets IRB dominance – Risk.net Skip to main content End of drawer navigation content Introduction of output floor means internal ratings’ popularity takes a hit, but isn’t quite out for the count For years, banks in the European Union have relied on credit risk models to calculate the bulk of their…